Breaking News
Sort by:
Top Post
Experimental Cancer Drug May Slow Inflammation Linked to Heart Disease
An experimental drug already tested as a potential treatment for cancer, lung, and Alzheimer’s disease […]
New State of the Art CT Scanner Unveiled at Maidstone Hospital
A brand-new state of the art CT scanner which provides medical staff with clear sharp […]
London Femtech Vira Health Scores £1.5M Seed Funding for Helping Women Cope with Menopause
The news is just in that Vira Health has raised £1.5 million in a seed […]
Northern Ireland Pens Deal with First DataBank for Clinical Decision Tool
Health and Social Care Northern Ireland (HSCNI) have penned a deal with First DataBank to […]
First Gynecological Procedures Performed with Medtronic Hugo ™ Robotic-Assisted Surgery System
Medtronic plc (NYSE:MDT), the global leader in medical technology, today announced the first gynecological (GYN) […]
Lilly and Kumquat Biosciences Announce Collaboration to Discover and Develop Novel Small Molecules that Stimulate Tumor-Specific Immune Responses
Loxo Oncology at Lilly, a research and development group of Eli Lilly and Company (NYSE: LLY), and […]
3D Printing Transforming Medical Implants: 4D Biomaterials Picks Up £1.6M Funding
A medtech company based in Nottingham, 4D Biomaterials, which has developed a new biomaterial used for […]
Amanda Pritchard Appointed NHS Chief Executive
Amanda Pritchard has today been appointed as the new Chief Executive Officer of NHS England. […]
FDA Accepts Application for Roche’s Faricimab for the Treatment of Neovascular Age-related Macular Degeneration (nAMD) and Diabetic Macular Edema (DME)
Roche (SIX: RO, ROG; OTCQX: RHHBY) today announced that the U.S. Food and Drug Administration […]
Medtronic Announces FDA Clearance and Results of Artificial Intelligence Algorithms for Cardiac Monitoring
Medtronic plc (NYSE:MDT), the global leader in medical technology, today announced U.S. Food and Drug […]
Theme Park Joins NHS Covid Vaccine Drive
Thorpe Park Resort will today (Thursday) join the roll-call of iconic locations to take part […]
- Eloxx Pharmaceuticals Announces Final Data Assessment from Phase 2 Combination Clinical Trial of ELX-02 in Class 1 Cystic Fibrosis Patients Read more
- Verge Genomics Announces Positive Safety and Tolerability Data from the Phase 1 Clinical Trial of VRG50635, a Potential Best-in-Class Therapeutic for All Forms of ALS Read more
- DEM BioPharma Appoints Wendy Young, Ph.D., to Scientific Advisory Board Read more
- Confo Therapeutics Enters into Research Collaboration for GPCR-Targeting Antibody Discovery with AbCellera Read more
- Vyriad Announces Expansion of T-Cell Lymphoma Trial at Mayo Clinic Read more